1. Preliminary Results 5 March 2008
Interim Results 6 September 2007

2. John Neilson
Finance Director

3. Sales analysis 2007 Sales change vs 2006
Volume
5.6%
Price / Mix
(2.4)%
Operations
3.2%
Exchange
(0.9)%
Total
(2.3)%

4. Regional sales* by destination 2007 Change vs 2006
(£m)
Volume
Price / Mix
Operations
Exchange
Total
Europe
92.5
3.4%
(1.5)%
1.9%
1.4%
3.3%
Americas
28.8
(5.5)%
4.4%
(1.1)%
(7.6)%
(8.7)%
Asia/Pacific
35.0
21.7%
(10.5)%
11.2%
(0.7)%
10.5%
156.3
5.6%
(2.4)%
3.2%
(0.9)%
2.3%
*Stated on a continuing operations basis

5. Income statement* Year ended 31 December 2007
2006
Group sales
156.3
152.8
Operating profit before exceptional items
18.3
20.0
Operating margin
11.7%
13.1%
Exceptional items
0.7
(1.0)
Net interest
(2.7)
(2.0)
Profit before tax
16.2
16.9
Tax
4.2
4.5
Profit for the year
12.0
12.4
*Stated on a continuing operations basis, excluding a loss before tax of £0.7m in 2007 (2006: £0.7m) relating to the BioFilm business

6. Earnings and Dividend Year ended 31 December 2007
2006
Earnings per share*
Basic
7.4p
7.7p
Diluted
7.6p
Before exceptional items
7.2p
8.1p
Dividend per ordinary share
4.45p
*Stated on a continuing operations basis

7. Balance sheet Non-current assets 122.1 118.9 Net current assets 28.9£m
2007
2006
Non-current assets
122.1
118.9
Net current assets
28.9
22.3
Non-current liabilities
(55.9)
(68.0)
95.1
73.2
Share capital and reserves
80.3
70.7
Retained earnings
14.8
2.5
Net debt
(27.3)
(27.0)
Gearing
28.7%
36.9%

8. Cash flow Year ended 31 December 2007
2006
Net cash inflow from operating activities
23.0
22.6
Net interest paid
(2.7)
(2.0)
Tax paid
(3.7)
(5.1)
Capital expenditure
(10.7)
(18.1)
Equity dividend paid
(7.2)
Issue of share capital -
0.7
Exchange
1.0
(0.2)
Increase in net debt
(0.3)
(9.3)
Interest cover*
6.5
9.5
*Calculated on operating profits before exceptional items

9. Peter Page
Chief Executive

10. 2007 Review Strong sales in second half are encouraging
USA customer change to gel well managed
Scottish manufacturing more stable
Good cash generation

11. 2008 Review Pricing takes precedence
Product development will enhance competitive advantages
Volume growth worldwide at 4-5% per annum
Current trading is in line with expectations